Quantcast

Latest Heart failure Stories

2014-08-30 12:21:03

Phase II feasibility trial provides first randomized sham-controlled data using vagus nerve stimulation to treat heart failure MARLBOROUGH, Mass., Aug. 30, 2014 /PRNewswire/ -- Boston Scientific has released the primary endpoint results from its NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) clinical trial, the first and only randomized sham-controlled clinical trial investigating vagus nerve stimulation (VNS) for the treatment of heart failure patients. Faiez Zannad, M.D.,...

2014-08-30 12:20:58

-- LCZ696 mortality benefit exceeded what was achieved with enalapril, an ACE-inhibitor, when replacing enalapril combined with current treatment regimen for HF-REF1 -- Study showed significantly more HF-REF patients on LCZ696 regimen were alive and had fewer hospitalizations than those given enalapril regimen1 -- Heart failure affects more than 600,000 Canadians18 and is responsible for 9 per...

2014-08-30 08:20:58

- Study showed significantly more HF-REF patients on LCZ696 regimen were alive, had fewer hospitalizations than those given enalapril regimen(1) EAST HANOVER, N.J., Aug. 30, 2014 /PRNewswire/ -- Today at the European Society of Cardiology congress and published simultaneously in the New England Journal of Medicine, Novartis revealed that its investigational heart failure medicine, LCZ696, was superior to ACE-inhibitor enalapril on key endpoints in the largest heart failure study ever...

2014-08-27 23:01:44

PHA has endorsed the American College of Chest Physicians guidelines for the management and treatment of pulmonary arterial hypertension in adults. Silver Spring, Md. (PRWEB) August 27, 2014 The American College of Chest Physicians(CHEST) recently released guidelines for the management and treatment of pulmonary arterial hypertension (PAH) in adults, Pharmacological Therapy for Pulmonary Arterial Hypertension in Adults: CHEST Guideline, in the journal CHEST. The guidelines are free to...

2014-08-26 08:29:21

The Tucson company manufactures the Total Artificial Heart, the world's only approved device that eliminates the source of end-stage biventricular failure, and the Freedom portable driver. TUCSON, Ariz., Aug. 26, 2014 /PRNewswire/ -- SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, is high on the Inc. 5000 named by the business magazine Inc. http://photos.prnewswire.com/prnvar/20140825/139411 "SynCardia manufactures the world's only FDA, Health Canada...

TENS machine being used to simulate the vagus nerve
2014-08-22 03:30:52

Chris Bunting, University of Leeds Stimulating nerves in your ear could improve the health of your heart, researchers have discovered. A team at the University of Leeds used a standard TENS machine like those designed to relieve labor pains to apply electrical pulses to the tragus, the small raised flap at the front of the ear immediately in front of the ear canal. The stimulation changed the influence of the nervous system on the heart by reducing the nervous signals that can drive...

heart thinkstock 452128839
2014-08-20 03:30:48

American Heart Association Rapid Access Journal Report U.S. hospitalizations and deaths from heart disease and stroke dropped significantly in the last decade, according to new research in the American Heart Association journal Circulation. “Interestingly, these improvements happened in a period when there were no real ‘miracle’ clinical advancements,” said Harlan Krumholz, M.D., S.M., lead author of the “most comprehensive report card to-date” on America’s progress in...

2014-08-13 08:29:50

A congenital heart defect brought Andrew Weaver close to death from end-stage biventricular heart failure. The SynCardia Heart kept him alive and helped build physical strength for his heart transplant. TUCSON, Ariz., Aug. 13, 2014 /PRNewswire/ -- Andrew Weaver and his wife, Heather, feared he wouldn't see their daughter, Haley, grow up because he was dying of heart failure. Instead, Andrew gets to cherish family moments that he would have missed, thanks to the SynCardia temporary Total...

2014-08-12 08:31:39

CLEVELAND, Aug. 12, 2014 /PRNewswire-USNewswire/ -- Juventas Therapeutics, Inc., a private clinical-stage company developing a drug-based approach to regenerative medicine today announced that it successfully completed the Phase I arm of the RETRO-HF clinical trial, and fully enrolled the Phase II arm that is evaluating the safety and preliminary clinical efficacy for retrograde infusion of JVS-100 in patients with heart failure....

2014-08-11 00:20:49

-- LCZ696 significantly reduced cardiovascular deaths in head to head study against enalapril, in addition to current best treatment, in patients with HF-REF EAST HANOVER, N.J., Aug. 11, 2014 /PRNewswire/ -- New data revealing the reduction in cardiovascular (CV) deaths with Novartis' LCZ696 in patients with heart failure with reduced ejection fraction (HF-REF) will be presented at the world's largest cardiology congress, the European Society of Cardiology (ESC) Congress 2014, on Sunday...


Latest Heart failure Reference Libraries

Circulation (journal)
2012-06-04 14:21:01

Circulation is a scientific journal published by Lippincott Williams & Wilkins on behalf of the American Heart Association. In 2008 the journal added six subspecialty publications: Circulation: Arrhythmia and Electrophysiology, Circulation: Heart Failure, Circulation: Cardiovascular Imaging, Circulation: Cardiovascular Interventions, Circulation: Cardiovascular Quality and Outcomes, and Circulation: Cardiovascular Genetics. Circulation publishes articles related to research in and the...

More Articles (1 articles) »
Word of the Day
monteith
  • A large punch-bowl of the eighteenth century, usually of silver and with a movable rim, and decorated with flutings and a scalloped edge. It was also used for cooling and carrying wine-glasses.
  • A kind of cotton handkerchief having white spots on a colored ground, the spots being produced by a chemical which discharges the color.
This word is possibly named after Monteith (Monteigh), 'an eccentric 17th-century Scotsman who wore a cloak scalloped at the hem.'
Related